From: Comprehensive profiling of immune-related genes in soft tissue sarcoma patients
 | Total set (n = 259) | Training set (n = 183) | Validation set (n = 76) |
---|---|---|---|
Age, years | 60.71 ± 14.59 | 60.51 ± 14.61 | 61.20 ± 14.64 |
Race | |||
 White | 226 | 160 | 66 |
 Other | 24 | 14 | 10 |
 Unknown | 9 | 9 | 0 |
Sex | |||
 Male | 118 | 78 | 40 |
 Female | 141 | 105 | 36 |
Tumor site | |||
 Extremity | 85 | 61 | 24 |
 Other | 174 | 122 | 52 |
Margin status | |||
 R0 | 154 | 107 | 47 |
 R1/2 | 78 | 57 | 21 |
 Unknown | 27 | 19 | 8 |
Metastasis | |||
 No | 120 | 87 | 33 |
 Yes | 56 | 35 | 21 |
 Unknown | 83 | 61 | 22 |
Radiotherapy | |||
 No | 140 | 101 | 39 |
 Yes | 73 | 49 | 24 |
 Unknown | 46 | 33 | 13 |
Histological type | |||
 Leiomyosarcoma | 104 | 72 | 32 |
 Dedifferentiated liposarcoma | 58 | 43 | 15 |
 UPS | 51 | 34 | 17 |
 Myxofibrosarcoma | 25 | 17 | 8 |
 Synovial sarcoma | 10 | 7 | 3 |
 Other | 11 | 10 | 1 |